Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ studyJ.F.R. Robertson, Matthew J. Ellis, Laura Emerson et al.|Breast Cancer Research and Treatment|2012Cited by 172